('mitral_valve_stenosis', 0.0005020981242451688)
('median_body', 0.0005020954320974941)
('MIR383', 0.0005020910272354964)
('SPIB', 0.0005020584664538664)
('RPL23', 0.0005018216338779097)
('atrium', 0.000501735260172229)
('COLEC10', 0.0005017224019837198)
('DNAJB6', 0.0005016383664823309)
('SLC45A3', 0.0005015434892896022)
('neuroblast', 0.0005015231878309865)
('OTUD5', 0.000501480546054171)
('olanzapine', 0.0005012853262960793)
('Endostar', 0.0005010505377743124)
('INF2', 0.0005010155181380526)
('epratuzumab', 0.0005007851954667232)
('microcytic_anemia', 0.0005005506951492012)
('SLC22A5', 0.0005005186910825688)
('KIF24', 0.0005004371967055764)
('dosage_compensation_by_inactivation_of_X_chromosome', 0.00050037224912347)
('disease_of_metabolism', 0.0005002549559554999)
('IPMK', 0.0005002099009209003)
('USP26', 0.0005001861305227272)
('type_IV_hypersensitivity', 0.0004998630162164563)
('LARP7', 0.0004997584091423605)
('Exemestane', 0.0004997550594030123)
('MCM8', 0.0004996787086693143)
('SLC23A2', 0.0004996076949872384)
('chaperone_complex', 0.0004993252063630241)
('unconventional_myosin_complex', 0.0004988181273998499)
('anorexia_nervosa', 0.0004986863727311675)
('mastitis', 0.0004985806450685011)
('Protein_S_human', 0.0004984028391389428)
('STAB2', 0.0004983790472791712)
('Enalapril', 0.0004982420556949839)
('primary_polycythemia', 0.0004982310466244167)
('definitive_erythrocyte_differentiation', 0.0004982310466244167)
('matrix_metallopeptidase_secretion', 0.0004982210131609304)
('carbohydrate_storage', 0.0004977298636637447)
('membranoproliferative_glomerulonephritis', 0.0004976672845049167)
('interleukin-21_production', 0.0004976558837980605)
('PRNCR1', 0.0004974097134866473)
('PTPN22', 0.0004972624138045621)
('Benralizumab', 0.0004972344363225225)
('renal_tubular_acidosis', 0.0004971909370033601)
('periplasmic_space', 0.0004969491689430208)
('pernicious_anemia', 0.0004969254876724021)
('microtubule_depolymerization', 0.0004966460459118426)
('glycine_dehydrogenase_(decarboxylating)_activity', 0.0004965965047806659)
('Apixaban', 0.0004962454139239627)
('4OHT', 0.0004961993527219114)
('HBD', 0.0004961156133911404)
('NFE2L1', 0.000495673649397757)
('duct_epithelial_cell', 0.000495627254167581)
('CPSF4', 0.0004954700289890363)
('CDC73', 0.0004954030350242199)
('cytochrome-c_oxidase_activity', 0.0004953353353700177)
('Verapamil', 0.000495332245833995)
('S-linalool_synthase_activity', 0.0004951654443493232)
('autoimmune_hepatitis', 0.0004951364982195694)
('SOD3', 0.0004950306673471593)
('CSNK1E', 0.000494986661911683)
('WDR20', 0.0004949822518561619)
('inclusion_body_myopathy_with_early-onset_Paget_disease_of_bone_with_or_without_frontotemporal_dementia_2', 0.0004948454735213387)
('MMP11', 0.0004944832167805738)
('chondrosarcoma_cell', 0.0004943855912634275)
('DDAH1', 0.0004942482761067245)
('neurodegenerative_disease', 0.0004941111493186457)
('FSCN1', 0.0004939847793320559)
('carotid_artery', 0.0004939842737381688)
('ENO2', 0.0004938824386853186)
('MIR663A', 0.0004934327809864906)
('SLC38A2', 0.0004934196886470197)
('vena_cava', 0.0004932755003609808)
('WFDC2', 0.0004926790617948654)
('MGAT5', 0.0004924024175401647)
('MIR665', 0.0004924019232370282)
('KCNRG', 0.0004917190488724539)
('PLCB2', 0.0004916836742122414)
('Quinacrine', 0.000491673569035882)
('JPX', 0.0004915639814372767)
('ado-trastuzumab emtansine', 0.0004914197806589507)
('mitochondrial_ribosome', 0.0004913283654623303)
('KRT90P', 0.0004911805631382609)
('Piperazine', 0.0004908099962753428)
('MIR3140', 0.000490784401270358)
('mannitol', 0.0004906714937436742)
('Nigericin', 0.0004904001180349263)
('fatty_liver_disease', 0.0004902512323880293)
('SIGIRR', 0.0004899832032800145)
('nasopharyngitis', 0.0004899483058317548)
('interleukin-7_receptor_binding', 0.0004898759869051645)
('MAPK15', 0.0004898752893081372)
('RPS17', 0.0004897896971475905)
('DEFA1', 0.0004897528612003557)
('DHX15', 0.000489554339634529)
('ANKRD17', 0.0004894711385699154)
('SQOR', 0.0004894111456998011)
('VANGL1', 0.0004892815329269654)
('LRRC1', 0.0004888853581275903)
('ADRB3', 0.0004888041611940702)
('Ticagrelor', 0.0004886191221235346)
('CD248', 0.0004886071413803763)
('GPR160', 0.0004885059486100404)
('CACNA1A', 0.0004883254233177677)
('OLIG2', 0.00048826674795044757)
('germ_cell_development', 0.0004881812425824896)
('Basiliximab', 0.0004881595541742126)
('epidermal_growth_factor_binding', 0.0004879960659819625)
('nephrosclerosis', 0.00048799022695620664)
('erythroleukemia_cell_line', 0.00048783243195840736)
('CDC7', 0.0004878028101459974)
('MUC13', 0.0004876024845627015)
('RPL13A', 0.0004875856460580904)
('KCNG1', 0.00048752963089543203)
('FOXK1', 0.0004875290467497761)
('epigenetic_reader', 0.0004874336500868755)
('atopic_dermatitis', 0.0004872118001628868)
('cardiac_muscle_cell_differentiation', 0.00048709887695005537)
('ZMYND8', 0.0004870942557221943)
('POLG', 0.0004870248135653124)
('CG-200745', 0.00048685053537888504)
('ATP2B1', 0.0004867238860204228)
('PRDM5', 0.00048649994234793297)
('Motavizumab', 0.0004863617704847248)
('amyloid_plaque', 0.00048632234986628327)
('H1-7', 0.0004862485837490258)
('Aminopterin', 0.00048619615222959595)
('submandibular_lymph_node', 0.00048615602733122134)
('ellagic acid', 0.00048613124240121265)
('CEP70', 0.00048580052143370133)
('thyroid-stimulating_hormone_secretion', 0.00048560911223491675)
